Trial Outcomes & Findings for A Clinical Comparison of 2 Multifocal Toric XR (Extended Range) Contact Lenses (NCT NCT03006458)

NCT ID: NCT03006458

Last Updated: 2020-06-01

Results Overview

Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

24 participants

Primary outcome timeframe

Baseline

Results posted on

2020-06-01

Participant Flow

Participant milestones

Participant milestones
Measure
Comfilcon A Then Omafilcon B
Participants were randomized to wear comfilcon A for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B Then Comfilcon A
Participants were randomized to wear omafilcon B for two weeks during the cross over study. omafilcon B: toric contact lens
First Intervention
STARTED
14
10
First Intervention
COMPLETED
14
7
First Intervention
NOT COMPLETED
0
3
Second Intervention
STARTED
14
10
Second Intervention
COMPLETED
14
10
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Comfilcon A Then Omafilcon B
Participants were randomized to wear comfilcon A for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B Then Comfilcon A
Participants were randomized to wear omafilcon B for two weeks during the cross over study. omafilcon B: toric contact lens
First Intervention
Unsatisfied Vision
0
3

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Study
n=24 Participants
Total Participants
Age, Categorical
<=18 years
0 Participants
n=24 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
n=24 Participants
Age, Categorical
>=65 years
0 Participants
n=24 Participants
Age, Continuous
56.2 years
STANDARD_DEVIATION 6.2 • n=24 Participants
Sex: Female, Male
Female
11 Participants
n=24 Participants
Sex: Female, Male
Male
13 Participants
n=24 Participants
Region of Enrollment
United Kingdom
24 participants
n=24 Participants

PRIMARY outcome

Timeframe: Baseline

Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Stability
3.2 units on a scale
Standard Deviation 1.5
2.9 units on a scale
Standard Deviation 0.9

PRIMARY outcome

Timeframe: 2 weeks

Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Stability
3.2 units on a scale
Standard Deviation 0.7
2.5 units on a scale
Standard Deviation 1.0

PRIMARY outcome

Timeframe: Baseline

Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Overall Toric Lens Fit Acceptance
3.3 units on a scale
Standard Deviation 0.5
3.2 units on a scale
Standard Deviation 0.6

PRIMARY outcome

Timeframe: 2 weeks

Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Overall Toric Lens Fit Acceptance
3.5 units on a scale
Standard Deviation 0.6
2.8 units on a scale
Standard Deviation 0.7

PRIMARY outcome

Timeframe: Baseline

Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Comfort
81.6 units on a scale
Standard Deviation 20.3
79.7 units on a scale
Standard Deviation 21.6

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Comfort
79.8 units on a scale
Standard Deviation 21.8
70.6 units on a scale
Standard Deviation 27.2

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Overall Satisfaction
63.0 units on a scale
Standard Deviation 31.4
63.3 units on a scale
Standard Deviation 34.4

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Dryness
80.4 units on a scale
Standard Deviation 24.7
77.2 units on a scale
Standard Deviation 24.1

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Visual Fluctuation/ Stability
81.0 units on a scale
Standard Deviation 16.1
73.8 units on a scale
Standard Deviation 25.5

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Handling
84.5 units on a scale
Standard Deviation 15.0
85.8 units on a scale
Standard Deviation 17.1

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Quality of Near Vision
38.5 units on a scale
Standard Deviation 30.5
56.4 units on a scale
Standard Deviation 28.9

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Quality of Intermediate Vision
50.2 units on a scale
Standard Deviation 29.5
65.3 units on a scale
Standard Deviation 25.6

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Quality of Distance Vision
86.2 units on a scale
Standard Deviation 13.7
67.3 units on a scale
Standard Deviation 25.5

PRIMARY outcome

Timeframe: 2 weeks

Subjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=20 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=17 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Quality of Vision While Driving During the Day
87.3 units on a scale
Standard Deviation 14.6
76.2 units on a scale
Standard Deviation 25.4

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=20 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=15 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Quality of Vision While Driving During the Night
78.0 units on a scale
Standard Deviation 18.6
67.0 units on a scale
Standard Deviation 23.4

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=23 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Ghosting at Near
66.5 units on a scale
Standard Deviation 35.0
78.1 units on a scale
Standard Deviation 27.0

PRIMARY outcome

Timeframe: 2 weeks

Subjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.

Outcome measures

Outcome measures
Measure
Comfilcon A
n=24 Participants
Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study. comfilcon A: toric contact lens
Omafilcon B
n=21 Participants
Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study. omafilcon B: toric contact lens
Ghosting at Distance
83.3 units on a scale
Standard Deviation 24.8
86.9 units on a scale
Standard Deviation 24.4

Adverse Events

Comfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Omafilcon B

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Myhanh Nguyen

CooperVision

Phone: 9257306716

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place